Momentum behind New Approach Methodologies (NAMs) has accelerated rapidly in recent years. Regulators, industry, and academia […]
The past 12 months have shown an incredible focus on New Approach Methodologies (NAMs) to reduce […]
The flurry of attention New Approach Methodologies (NAMs) have recently received has come with a range […]
The traditional focus of preclinical studies has always been on safety. And for good reason. Many […]
The FDA’s Innovative Science and Technology Approaches for New Drugs (ISTAND) Program is one of the clearest windows into […]
2026 is already promising to be another huge year for the advancement of New Approach Methodologies […]
Medical research saw a tectonic shift in 2025. The promise of New Approach Methodologies (NAMs) to […]
New Approach Methodologies (NAMs) have the potential to transform global drug development in the next few […]